Fuji Pharma

Live  

Fuji Pharma is a Japanese pharmaceutical company that was founded in 1965. The company specializes in the research, development, production, and sale of pharmaceutical products, with a focus on prescription medicines and OTC drugs. Fuji Pharma’s headquarters are located in Tokyo, Japan.
The company’s main areas of focus include gastroenterology, central nervous system disorders, and dermatology. Fuji Pharma has a strong commitment to research and development, investing a significant portion of its revenue into developing new and innovative medicines.
The company also has a global presence, with subsidiaries and affiliates in countries such as the United States, China, and Thailand. Fuji Pharma’s international operations focus on expanding its business and making its products available in new markets.
In addition to its core pharmaceutical business, Fuji Pharma is also involved in various community initiatives and supports projects related to healthcare and education.
Fuji Pharma’s mission is to contribute to the health and well-being of people worldwide by providing high-quality medicines and healthcare solutions. The company strives to achieve this through its continuous research and development efforts and partnerships with global organizations and healthcare professionals.

MS4gSGlzdG 9yaWNhbCBy b290czogVG hlIEZ1amkg UGhhcm1hIG NvbXBhbnkg aGFzIGEgbG 9uZyBoaXN0 b3J5LCB0cm FjaW5nIGl0 cyByb290cy BiYWNrIHRv IDE5MzQgd2 hlbiBpdCB3 YXMgZXN0YW JsaXNoZWQg YXMgYSBwaG FybWFjZXV0 aWNhbCBjaG VtaWNhbCBj b21wYW55IG luIEphcGFu Ljxicj4yLi BXaWRlIHJh bmdlIG9mIH Byb2R1Y3Rz OiBUaGUgY2 9tcGFueSBo YXMgYSBkaX ZlcnNlIHBv cnRmb2xpby BvZiBwcm9k dWN0cyB0aG F0IGNvdmVy IHZhcmlvdX MgYXJlYXMg b2YgaGVhbH RoY2FyZSBp bmNsdWRpbm cgcGhhcm1h Y2V1dGljYW xzLCBtZWRp Y2FsIGRldm ljZXMsIGRp YWdub3N0aW NzLCBhbmQg ZnVuY3Rpb2 5hbCBmb29k cy48YnI+My 4gRm9jdXMg b24gaW5ub3 ZhdGlvbjog RnVqaSBQaG FybWEgaW52 ZXN0cyBoZW F2aWx5IGlu IHJlc2Vhcm NoIGFuZCBk ZXZlbG9wbW VudCB0byBk ZXZlbG9wIG 5ldyBtZWRp Y2luZXMgYW 5kIHRyZWF0 bWVudHMgZm 9yIHZhcmlv dXMgZGlzZW FzZXMgYW5k IGhlYWx0aC Bjb25kaXRp b25zLjxicj 40LiBRdWFs aXR5IGNvbn Ryb2w6IFRo ZSBjb21wYW 55IGhhcyBz dHJpY3QgcX VhbGl0eSBj b250cm9sIG 1lYXN1cmVz IGluIHBsYW NlIHRvIGVu c3VyZSB0aG Ugc2FmZXR5 IGFuZCBlZm ZlY3RpdmVu ZXNzIG9mIG l0cyBwcm9k dWN0cy48Yn I+NS4gR2xv YmFsIHByZX NlbmNlOiBX aGlsZSB0aG UgY29tcGFu eSBpcyBiYX NlZCBpbiBK YXBhbiwgaX QgaGFzIGEg Z2xvYmFsIH ByZXNlbmNl IHdpdGggb2 ZmaWNlcyBh bmQgc3Vic2 lkaWFyaWVz IGluIHZhcm lvdXMgY291 bnRyaWVzLC BpbmNsdWRp bmcgdGhlIF VuaXRlZCBT dGF0ZXMsIE NoaW5hLCBh bmQgRXVyb3 BlLjxicj42 LiBQYXJ0bm Vyc2hpcHMg YW5kIGNvbG xhYm9yYXRp b25zOiBGdW ppIFBoYXJt YSBoYXMgZX N0YWJsaXNo ZWQgcGFydG 5lcnNoaXBz IGFuZCBjb2 xsYWJvcmF0 aW9ucyB3aX RoIGxlYWRp bmcgcmVzZW FyY2ggaW5z dGl0dXRpb2 5zIGFuZCBw aGFybWFjZX V0aWNhbCBj b21wYW5pZX MsIGFsbG93 aW5nIGZvci B0aGUgZXhj aGFuZ2Ugb2 Yga25vd2xl ZGdlIGFuZC ByZXNvdXJj ZXMgdG8gYW R2YW5jZSBo ZWFsdGhjYX JlLjxicj43 LiBDb21taX RtZW50IHRv IGNvcnBvcm F0ZSBzb2Np YWwgcmVzcG 9uc2liaWxp dHk6IFRoZS Bjb21wYW55 IGFjdGl2ZW x5IHBhcnRp Y2lwYXRlcy BpbiBpbml0 aWF0aXZlcy B0aGF0IGNv bnRyaWJ1dG UgdG8gdGhl IHdlbGwtYm Vpbmcgb2Yg c29jaWV0eS wgaW5jbHVk aW5nIHN1cH BvcnRpbmcg aGVhbHRoY2 FyZSBhY2Nl c3MgaW4gZG V2ZWxvcGlu ZyBjb3VudH JpZXMgYW5k IGVudmlyb2 5tZW50YWwg c3VzdGFpbm FiaWxpdHku PGJyPjguIE VtcGxveWVl IGRldmVsb3 BtZW50OiBG dWppIFBoYX JtYSB2YWx1 ZXMgaXRzIG VtcGxveWVl cyBhbmQgaW 52ZXN0cyBp biB0aGVpci BkZXZlbG9w bWVudCB0aH JvdWdoIHRy YWluaW5nIG FuZCBjYXJl ZXIgZ3Jvd3 RoIG9wcG9y dHVuaXRpZX MuPGJyPjku IFN0cm9uZy BmaW5hbmNp YWwgcGVyZm 9ybWFuY2U6 IFRoZSBjb2 1wYW55IGhh cyBhIHNvbG lkIGZpbmFu Y2lhbCB0cm FjayByZWNv cmQsIGRlbW 9uc3RyYXRp bmcgaXRzIH N0YWJpbGl0 eSBhbmQgc3 VjY2VzcyBp biB0aGUgcG hhcm1hY2V1 dGljYWwgaW 5kdXN0cnku PGJyPjEwLi BDb21taXRt ZW50IHRvIG V0aGljYWwg cHJhY3RpY2 VzOiBGdWpp IFBoYXJtYS Bmb2xsb3dz IGV0aGljYW wgYnVzaW5l c3MgcHJhY3 RpY2VzIGFu ZCBhZGhlcm VzIHRvIHN0 cmljdCBjb2 1wbGlhbmNl IHN0YW5kYX JkcyB0byBw cm9tb3RlIH RyYW5zcGFy ZW5jeSBhbm QgdHJ1c3Qg d2l0aCBzdG FrZWhvbGRl cnMu

RnVqaSBQaG FybWEgaXMg YSBKYXBhbm VzZSBwaGFy bWFjZXV0aW NhbCBjb21w YW55IHdpdG ggYSBidXNp bmVzcyBtb2 RlbCBmb2N1 c2VkIG9uIH Jlc2VhcmNo IGFuZCBkZX ZlbG9wbWVu dCwgcHJvZH VjaW5nIGFu ZCBtYXJrZX RpbmcgYnJh bmRlZCBpbm 5vdmF0aXZl IHByZXNjcm lwdGlvbiBk cnVncywgYW 5kIHByb3Zp ZGluZyBtZW RpY2FsIGRl dmljZSBhbm QgaGVhbHRo Y2FyZSBzZX J2aWNlcy4g VGhleSBhbH NvIGhhdmUg YSBzdHJvbm cgZm9jdXMg b24gbGljZW 5zaW5nIGFu ZCBwYXJ0bm Vyc2hpcCBh Z3JlZW1lbn RzIHdpdGgg b3RoZXIgY2 9tcGFuaWVz IHRvIGV4cG FuZCB0aGVp ciBwcm9kdW N0IHBvcnRm b2xpbyBhbm QgZ2xvYmFs IHByZXNlbm NlLiBBZGRp dGlvbmFsbH ksIHRoZSBj b21wYW55IG 1haW50YWlu cyBhIHN0cm 9uZyBlbXBo YXNpcyBvbi BldGhpY2Fs IGFuZCBzb2 NpYWxseSBy ZXNwb25zaW JsZSBwcmFj dGljZXMsIG FzIHdlbGwg YXMgY29udG ludW91cyBp bXByb3ZlbW VudCB0aHJv dWdoIGludm VzdG1lbnQg aW4gdGVjaG 5vbG9neSBh bmQgaHVtYW 4gcmVzb3Vy Y2VzLg==

The sensitivity of Fuji Pharma’s earnings, cash flow, and valuation to changes in interest rates can be influenced by several factors:
1. Earnings Sensitivity: Interest rates can impact Fuji Pharma’s profitability through various channels. Higher interest rates may lead to increased borrowing costs if the company has variable-rate debt. This could reduce net income as interest expenses rise. Conversely, lower interest rates can enhance earnings by reducing debt servicing costs. Additionally, interest rate changes can affect the demand for healthcare products and services, particularly if they influence consumer spending or the financial health of healthcare providers.
2. Cash Flow Sensitivity: Cash flow is highly sensitive to interest rates, especially if Fuji Pharma relies on external financing to support its operations or expansion. Higher rates may constrain cash flows due to increased interest payments. Moreover, if the company invests in projects or R&D funded by debt, the cost of capital becomes crucial; higher rates could diminish the attractiveness of such investments, potentially impacting future cash flows.
3. Valuation Sensitivity: The company’s valuation is closely tied to the discount rate used in financial models to determine the present value of future cash flows. When interest rates rise, the discount rate typically increases, which can lead to lower valuations. This is particularly relevant for growth-oriented companies like Fuji Pharma, where much of their value is derived from anticipated future earnings. Conversely, lower interest rates can lead to higher valuations by reducing the discount rate.
Overall, Fuji Pharma’s financial performance and market valuation are affected by interest rate changes, making it essential for the company to monitor economic conditions and adjust its financial strategies accordingly.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn dIZkU1V1Rl aTVnZEVVU2 tvVGMud2Vi cCIgYWx0PS JGdWppIFBo YXJtYSIgdG l0bGU9IkZ1 amkgUGhhcm 1hIiAgY2xh c3M9ImltZy 1mbHVpZCIg aGVpZ2h0PT kwIHdpZHRo PTkwIGxvYW Rpbmc9J2xh enknIHN0eW xlPSdib3Jk ZXItcmFkaX VzOiA2cHg7 Jz4KCiAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nZm xleDogMTsg dGV4dC1hbG lnbjogY2Vu dGVyOyBtYX JnaW4tbGVm dDogNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdm b250LXNpem U6IDI2cHg7 IGNvbG9yOi AjMzMzOyBt YXJnaW4tYm 90dG9tOiAx NXB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICDwn5 OIIFdhbnQg dG8gcmVhZC Btb3JlIGFi b3V0IEZ1am kgUGhhcm1h PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TmiBZ b3VyIGZyZW UgY29weSBv ZiA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGlz IHdhaXRpbm cKICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9wPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxMnB4 OyBmb250LX NpemU6IDEz cHg7IGNvbG 9yOiAjNDQ0 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIG5vdyBh bmQgZ2V0IG 91ciBmcmVl IGVCb29rIA ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG I+VGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrczwvYj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDE2cHg7IG ZvbnQtc2l6 ZTogMTRweD sgY29sb3I6 ICM0NDQ7IG ZvbnQtZmFt aWx5OiAtYX BwbGUtc3lz dGVtLCBCbG lua01hY1N5 c3RlbUZvbn QsIFNlZ29l IFVJLCBSb2 JvdG8sIEhl bHZldGljYS BOZXVlLCBz YW5zLXNlcm lmOyBsaW5l LWhlaWdodD ogMS42Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBI YXZlIHlvdS BoZWFyZCBh Ym91dCBvdX Igc2hvcnQg PHN0cm9uZy BzdHlsZT0n Zm9udC13ZW lnaHQ6IDYw MDsnPkRhaW x5IFZpZGVv IE5ld3NsZX R0ZXI8L3N0 cm9uZz4/Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdo dHRwczovL3 d3dy5pbnNp Z2h0ZnVsdm FsdWUuY29t L25ld3NsZX R0ZXIucGhw JyB0YXJnZX Q9J19ibGFu aycgc3R5bG U9J2NvbG9y OiAjMDA3Qk ZGOyB0ZXh0 LWRlY29yYX Rpb246IG5v bmU7IGZvbn Qtd2VpZ2h0 OiA1MDA7IG 1hcmdpbi1s ZWZ0OiA2cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBG aW5kIG91dC Btb3JlCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgCi AgICAgICAg CiAgICAgIC AgPHNwYW4g Y2xhc3M9J2 JsdXJyZWQt dGV4dCc+Ci AgICAgICAg ICAgIE1TNG dWR2hsSUcg TnZiWEJoYm 5rZyBkMkZ6 SUdadmRXID VrWldRZ2FX NGcgTVRrME 5pQmhjeSBC T2FXaHZiaU JRIGIzVnNk R2xqWlMgQk RieTRzSUV4 MCBaQzRnWW 5rZ1ZHIDl5 ZFNCTGFYTm 8gYVN3Z1lT QndhRyBGeW JXRmphWE4w IElIZG9ieU JrWlggWmxi Rzl3WldRZy BZU0J3YjNW c2RHIGxqWl NBb1lTQnog YjJaMExDQn RiMiBsemRD QnRZWE56IE lHOW1JRzFo ZEcgVnlhV0 ZzTENCMCBl WEJwWTJGc2 JIIGtnWTI5 dWMybHogZE dsdVp5QnZa aSBCM2FHVm hkQ0JuIFpY SnRJRzl5SU cgOTBhR1Z5 SUhOMSBZbk 4wWVc1alpY IE1zSUdGd2 NHeHAgWldR Z2RHOGdkRy BobElHSnZa SGtnIGRHOG djbVZzYVcg VjJaU0J6Yj NKbCBibVZ6 Y3lCaGJtIF FnYVc1bWJH RnQgYldGMG FXOXVLUyBC bWIzSWdkSE psIFlYUnBi bWNnWW4gVn libk11UEdK eSBQakl1SU VsdUlEIEU1 TlRBc0lIUm 8gWlNCamIy MXdZVyA1NU lHTm9ZVzVu IFpXUWdhWF J6SUcgNWhi V1VnZEc4Zy BSblZxYVNC TlpXIFJwWT JGc0lFbHUg WkhWemRISn BaWCBNZ1Ey OHVMQ0JNIG RHUXVJR0Z1 WkMgQmxlSE JoYm1SbCBa Q0JwZEhNZ2 NIIEp2WkhW amRDQnMgYV c1bElIUnZJ RyBsdVkyeD FaR1VnIGJH bHVhVzFsYm 4gUnpMQ0J2 YVc1MCBiV1 Z1ZEhNc0lH IEZ1WkNCdm RHaGwgY2lC d2FHRnliVy BGalpYVjBh V05oIGJDQn djbTlrZFcg TjBjeTQ4WW 5JKyBNeTRn U1c0Z2RHIG hsSURFNU5q QnogTENCR2 RXcHBJRSAx bFpHbGpZV3 dnIFNXNWtk WE4wY20gbG xjeUJEYnk0 cyBJRXgwWk M0Z2JXIFZ5 WjJWa0lIZH AgZEdnZ1Ju VnFhUyBCWl lXdDFhR2x1 IElFTnZMaX dnVEggUmtM aUIwYnlCbS BiM0p0SUVa MWFtIGtnVU doaGNtMWgg SUVOdkxpd2 dUSCBSa0xq eGljajQwIE xpQkpiaUF4 T1QgWTBMQ0 IwYUdVZyBZ Mjl0Y0dGdW VTIEJzWVhW dVkyaGwgWk NCcGRITWdj RyA5d2RXeG hjaUJ3IGNt OWtkV04wSU UgdDViMnQx YzJWdSBMQ0 JoSUhSdmNH IGxqWVd3Z1 lXNWwgYzNS b1pYUnBZeS BCbWIzSWdk SEpsIFlYUn BibWNnYlgg VnpZMnhsSU hCaCBhVzR1 UEdKeVBqIF V1SUVsdUlE RTUgTmpnc0 lFWjFhbSBr Z1VHaGhjbT FoIElHSmxZ MkZ0WlMgQj BhR1VnWm1s eSBjM1FnU2 1Gd1lXIDVs YzJVZ2NHaG ggY20xaFky VjFkRyBsal lXd2dZMjl0 IGNHRnVlU0 IwYnkgQnBi blJ5YjJSMS BZMlVnWVNC emIyIFowSU dOaGNITjEg YkdVZ2JXRn VkVyBaaFkz UjFjbWx1IF p5QnNhVzVs TGogeGljaj QyTGlCSiBi aUF4T1RjMk xDIEJHZFdw cElGQm8gWV hKdFlTQmxj MyBSaFlteH BjMmhsIFpD QmhJSEpsYz IgVmhjbU5v SUdGdSBaQ0 JrWlhabGJH IDl3YldWdW RDQmogWlc1 MFpYSWdkRy A4Z1ptOWpk WE1nIGIyNG dhVzV1YjMg WmhkR2wyWl NCayBjblZu SUdScGMyIE 52ZG1WeWVT QmggYm1RZ1 pHVjJaVyB4 dmNHMWxibl F1IFBHSnlQ amN1SUUgbH VJREl3TURN cyBJRVoxYW 1rZ1VHIGho Y20xaElHRm ogY1hWcGNt VmtJRyBFZ2 JXRnVkV1po IFkzUjFjbW x1WnkgQm1Z V05wYkdsMC BlU0JwYmlC VGRYIHBvYj NVc0lFTm8g YVc1aExDQm hjeSBCd1lY SjBJRzltIE lHbDBjeUJs ZUggQmhibk 5wYjI0ZyBh VzUwYnlCMG FHIFVnYVc1 MFpYSnUgWV hScGIyNWhi QyBCdFlYSn JaWFF1IFBH SnlQamd1SU UgbHVJREl3 TVRFcyBJRV oxYW1rZ1VH IGhoY20xaE lHRmogY1hW cGNtVmtJRy BFZ01UQXdK U0J6IGRHRn JaU0JwYmkg QkNZVzVuYT I5ciBJRUpw YjJ4dloyIG xqWVd3Z1VI SnYgWkhWam RITWdRMiA4 dUxDQk1kR1 F1IExDQmhJ RzFoYm4gVm 1ZV04wZFhK bCBjaUJ2Wm lCd2FHIEZ5 YldGalpYVj AgYVdOaGJD QndjbSA5a2 RXTjBjeXdn IGRtRmpZMm x1WlggTXNJ R0Z1WkNCdC BaV1JwWTJG c0lHIFJsZG 1salpYTXMg SUhSdklITj BjbSBWdVoz Um9aVzRnIG FYUnpJSEJ5 WlggTmxibU 5sSUdsdSBJ SFJvWlNCVG IzIFYwYUdW aGMzUWcgUV hOcFlXNGdi VyBGeWEyVj BManhpIGNq NDVMaUJKYm kgQXlNREV6 TENCRyBkV3 BwSUZCb1lY IEp0WVNCbG MzUmggWW14 cGMyaGxaQy BCaElITjFZ bk5wIFpHbG hjbmtnYVcg NGdTVzVrYj I1bCBjMmxo SUhSdklIIE 4wY21WdVoz Um8gWlc0Z2 FYUnpJSCBC eVpYTmxibU 5sIElHbHVJ SFJvWlMgQn laV2RwYjI0 dSBQR0p5UG pFd0xpIEJV YUdVZ1kyOX QgY0dGdWVl S0FtWCBNZ2 JXRnBiaUIw IGFHVnlZWE JsZFggUnBZ eUJoY21WaC BjeUJwYm1O c2RXIFJsSU dSbGNtMWgg ZEc5c2IyZD VMQyBCd1lX bHVJRzFoIG JtRm5aVzFs Ym4gUXNJR0 5oY21ScCBi M1poYzJOMW JHIEZ5SUdS cGMyVmggYz JWekxDQmhi bSBRZ2NtVn pjR2x5IFlY UnZjbmtnWk cgbHpaV0Z6 WlhNdQogIC AgICAgIDwv c3Bhbj4KIC AgICAgICAK ICAgICAgIC A=
See Company Q&A